Skip to main content
Top
Published in: Current Neurology and Neuroscience Reports 2/2012

01-04-2012 | Headache (I Garza, Section Editor)

Recent Advances in Diagnostic Strategies for Giant Cell Arteritis

Authors: Tanaz A. Kermani, Kenneth J. Warrington

Published in: Current Neurology and Neuroscience Reports | Issue 2/2012

Login to get access

Abstract

Giant cell arteritis (GCA) is a systemic vasculitis that affects the aorta and its major branches. Involvement of the ciliary artery can result in ischemic optic neuropathy and subsequent blindness, which is typically irreversible. If GCA is suspected, treatment with glucocorticoids should be initiated promptly to prevent further vision loss. However, given the need for prolonged therapy with glucocorticoids and the morbidity associated with their use, diagnosis should be confirmed. Clinical features and laboratory findings are neither sensitive nor specific for GCA. The mainstay of diagnosis remains histopathologic examination of a section of the superficial temporal artery. Several imaging studies have been used to evaluate the temporal artery but, at present, their utility as alternatives to a temporal artery biopsy is limited. Recent advances in imaging modalities have allowed detailed noninvasive imaging of the large arteries and are a useful adjunct for the diagnosis of GCA, particularly in patients with primarily large-vessel involvement in whom temporal artery biopsy is often negative.
Literature
1.
go back to reference •• Salvarani C, Cantini F, Hunder GG: Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234-45. This is an excellent general review of GCA and polymyalgia rheumatica, a related condition. PubMedCrossRef •• Salvarani C, Cantini F, Hunder GG: Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234-45. This is an excellent general review of GCA and polymyalgia rheumatica, a related condition. PubMedCrossRef
2.
go back to reference Kermani TA, Schafer VS, Crowson CS, et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis. 2010;69:780–1.PubMedCrossRef Kermani TA, Schafer VS, Crowson CS, et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis. 2010;69:780–1.PubMedCrossRef
3.
go back to reference •• Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, et al.: Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61:1454–61. This is a literature review of the epidemiology of GCA and the geographic differences in incidence. PubMedCrossRef •• Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, et al.: Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61:1454–61. This is a literature review of the epidemiology of GCA and the geographic differences in incidence. PubMedCrossRef
4.
go back to reference • Crowson CS, Matteson EL, Myasoedova E, et al.: The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63:633–9. Using population-based incidence cohorts of several rheumatic diseases, estimates of the lifetime risk of autoimmune conditions in adults in the United States are provided. PubMedCrossRef • Crowson CS, Matteson EL, Myasoedova E, et al.: The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63:633–9. Using population-based incidence cohorts of several rheumatic diseases, estimates of the lifetime risk of autoimmune conditions in adults in the United States are provided. PubMedCrossRef
5.
go back to reference Aiello PD, Trautmann JC, McPhee TJ, et al. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550–5.PubMed Aiello PD, Trautmann JC, McPhee TJ, et al. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550–5.PubMed
6.
go back to reference Salvarani C, Cimino L, Macchioni P, et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum. 2005;53:293–7.PubMedCrossRef Salvarani C, Cimino L, Macchioni P, et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum. 2005;53:293–7.PubMedCrossRef
7.
go back to reference Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore). 2000;79:283–92.CrossRef Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore). 2000;79:283–92.CrossRef
8.
go back to reference Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522–31.PubMedCrossRef Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522–31.PubMedCrossRef
9.
go back to reference • Kermani TA, Matteson EL, Hunder GG, Warrington KJ: Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. The Journal of rheumatology. 2009;36:2277–83. This is the largest clinical series of the features and prognosis of symptomatic lower extremity vasculitis, a rare and likely under-recognized complication from GCA. PubMedCrossRef • Kermani TA, Matteson EL, Hunder GG, Warrington KJ: Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. The Journal of rheumatology. 2009;36:2277–83. This is the largest clinical series of the features and prognosis of symptomatic lower extremity vasculitis, a rare and likely under-recognized complication from GCA. PubMedCrossRef
10.
go back to reference Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3532–7.PubMedCrossRef Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3532–7.PubMedCrossRef
11.
go back to reference Proven A, Gabriel SE, Orces C, et al. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum. 2003;49:703–8.PubMedCrossRef Proven A, Gabriel SE, Orces C, et al. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum. 2003;49:703–8.PubMedCrossRef
12.
go back to reference Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–8.PubMedCrossRef Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–8.PubMedCrossRef
13.
go back to reference Brack A, Martinez-Taboada V, Stanson A, et al. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42:311–7.PubMedCrossRef Brack A, Martinez-Taboada V, Stanson A, et al. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42:311–7.PubMedCrossRef
14.
go back to reference Schmidt WA, Moll A, Seifert A, et al. Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47:1406–8.CrossRef Schmidt WA, Moll A, Seifert A, et al. Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47:1406–8.CrossRef
15.
go back to reference Schmidt WA, Natusch A, Moller DE, et al. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol. 2002;20:309–18.PubMed Schmidt WA, Natusch A, Moller DE, et al. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol. 2002;20:309–18.PubMed
16.
go back to reference Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246–9.PubMedCrossRef Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246–9.PubMedCrossRef
17.
go back to reference • Agard C, Barrier JH, Dupas B, et al.: Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum. 2008;59:670–6. This is a study highlighting the prevalence of incidentally noted aortic abnormalities using computed tomography in subjects with newly diagnosed GCA. PubMedCrossRef • Agard C, Barrier JH, Dupas B, et al.: Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum. 2008;59:670–6. This is a study highlighting the prevalence of incidentally noted aortic abnormalities using computed tomography in subjects with newly diagnosed GCA. PubMedCrossRef
18.
go back to reference Aschwanden M, Kesten F, Stern M, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis. 2010;69:1356–9.PubMedCrossRef Aschwanden M, Kesten F, Stern M, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis. 2010;69:1356–9.PubMedCrossRef
19.
20.
go back to reference Younge BR, Cook Jr BE, Bartley GB, et al. Initiation of glucocorticoid therapy: before or after temporal artery biopsy? Mayo Clin Proc. 2004;79:483–91.PubMedCrossRef Younge BR, Cook Jr BE, Bartley GB, et al. Initiation of glucocorticoid therapy: before or after temporal artery biopsy? Mayo Clin Proc. 2004;79:483–91.PubMedCrossRef
21.
go back to reference Walvick MD, Walvick MP. Giant Cell Arteritis: Laboratory Predictors of a Positive Temporal Artery Biopsy. Ophthalmology. 2011;118:1201–4.PubMedCrossRef Walvick MD, Walvick MP. Giant Cell Arteritis: Laboratory Predictors of a Positive Temporal Artery Biopsy. Ophthalmology. 2011;118:1201–4.PubMedCrossRef
22.
go back to reference Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis. 1989;48:667–71.PubMedCrossRef Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis. 1989;48:667–71.PubMedCrossRef
23.
go back to reference Pountain GD, Calvin J, Hazleman BL. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol. 1994;33:550–4.PubMedCrossRef Pountain GD, Calvin J, Hazleman BL. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol. 1994;33:550–4.PubMedCrossRef
24.
go back to reference Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol. 1996;35:1161–8.PubMedCrossRef Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol. 1996;35:1161–8.PubMedCrossRef
25.
go back to reference Parikh M, Miller NR, Lee AG, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006;113:1842–5.PubMedCrossRef Parikh M, Miller NR, Lee AG, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006;113:1842–5.PubMedCrossRef
26.
go back to reference Achkar AA, Lie JT, Hunder GG, et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med. 1994;120:987–92.PubMed Achkar AA, Lie JT, Hunder GG, et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med. 1994;120:987–92.PubMed
27.
go back to reference Ray-Chaudhuri N, Kine DA, Tijani SO, et al. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol. 2002;86:530–2.PubMedCrossRef Ray-Chaudhuri N, Kine DA, Tijani SO, et al. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol. 2002;86:530–2.PubMedCrossRef
28.
go back to reference Salvarani C, Crowson CS, O’Fallon WM, et al. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum. 2004;51:264–8.PubMedCrossRef Salvarani C, Crowson CS, O’Fallon WM, et al. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum. 2004;51:264–8.PubMedCrossRef
29.
go back to reference Niederkohr RD, Levin LA. A Bayesian analysis of the true sensitivity of a temporal artery biopsy. Invest Ophthalmol Vis Sci. 2007;48:675–80.PubMedCrossRef Niederkohr RD, Levin LA. A Bayesian analysis of the true sensitivity of a temporal artery biopsy. Invest Ophthalmol Vis Sci. 2007;48:675–80.PubMedCrossRef
30.
go back to reference Taylor-Gjevre R, Vo M, Shukla D, Resch L. Temporal artery biopsy for giant cell arteritis. J Rheumatol. 2005;32:1279–82.PubMed Taylor-Gjevre R, Vo M, Shukla D, Resch L. Temporal artery biopsy for giant cell arteritis. J Rheumatol. 2005;32:1279–82.PubMed
31.
go back to reference Mahr A, Saba M, Kambouchner M, et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? Ann Rheum Dis. 2006;65:826–8.PubMedCrossRef Mahr A, Saba M, Kambouchner M, et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? Ann Rheum Dis. 2006;65:826–8.PubMedCrossRef
32.
go back to reference Dasgupta B. Concise guidance: diagnosis and management of giant cell arteritis. Clin Med. 2010;10:381–6.PubMed Dasgupta B. Concise guidance: diagnosis and management of giant cell arteritis. Clin Med. 2010;10:381–6.PubMed
33.
go back to reference Ponge T, Barrier JH, Grolleau JY, et al. The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis. J Rheumatol. 1988;15:997–1000.PubMed Ponge T, Barrier JH, Grolleau JY, et al. The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis. J Rheumatol. 1988;15:997–1000.PubMed
34.
go back to reference Boyev LR, Miller NR, Green WR. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol. 1999;128:211–5.PubMedCrossRef Boyev LR, Miller NR, Green WR. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol. 1999;128:211–5.PubMedCrossRef
35.
go back to reference Danesh-Meyer HV, Savino PJ, Eagle Jr RC, et al. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuroophthalmol. 2000;20:213–5.PubMedCrossRef Danesh-Meyer HV, Savino PJ, Eagle Jr RC, et al. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuroophthalmol. 2000;20:213–5.PubMedCrossRef
36.
go back to reference Pless M, Rizzo 3rd JF. Lamkin JC, Lessell S: Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuroophthalmol. 2000;20:216–8.PubMedCrossRef Pless M, Rizzo 3rd JF. Lamkin JC, Lessell S: Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuroophthalmol. 2000;20:216–8.PubMedCrossRef
37.
go back to reference Breuer GS, Nesher G, Nesher R. Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis. J Rheumatol. 2009;36:794–6.PubMedCrossRef Breuer GS, Nesher G, Nesher R. Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis. J Rheumatol. 2009;36:794–6.PubMedCrossRef
38.
go back to reference •• Blockmans D, Bley T, Schmidt W: Imaging for large-vessel vasculitis. Current opinion in rheumatology. 2009;21:19–28. This is a review of PET, MRI, and US for evaluation of patients with GCA by leading experts in this field. PubMedCrossRef •• Blockmans D, Bley T, Schmidt W: Imaging for large-vessel vasculitis. Current opinion in rheumatology. 2009;21:19–28. This is a review of PET, MRI, and US for evaluation of patients with GCA by leading experts in this field. PubMedCrossRef
39.
go back to reference Schmidt WA, Kraft HE, Vorpahl K, et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337:1336–42.PubMedCrossRef Schmidt WA, Kraft HE, Vorpahl K, et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337:1336–42.PubMedCrossRef
40.
go back to reference Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005;142:359–69.PubMed Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005;142:359–69.PubMed
41.
go back to reference Karahaliou M, Vaiopoulos G, Papaspyrou S, et al. Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther. 2006;8:R116.PubMedCrossRef Karahaliou M, Vaiopoulos G, Papaspyrou S, et al. Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther. 2006;8:R116.PubMedCrossRef
42.
go back to reference •• Schmidt WA, Seifert A, Gromnica-Ihle E, et al.: Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47:96–101. This study used systematic US of several arterial beds in 176 patients with newly diagnosed GCA and highlights the prevalence of incidentally noted findings of vasculitis in multiple arterial beds in GCA. CrossRef •• Schmidt WA, Seifert A, Gromnica-Ihle E, et al.: Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47:96–101. This study used systematic US of several arterial beds in 176 patients with newly diagnosed GCA and highlights the prevalence of incidentally noted findings of vasculitis in multiple arterial beds in GCA. CrossRef
43.
go back to reference Bley TA, Uhl M, Carew J, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol. 2007;28:1722–7.PubMedCrossRef Bley TA, Uhl M, Carew J, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol. 2007;28:1722–7.PubMedCrossRef
44.
go back to reference Bley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 2008;58:2574–8.PubMedCrossRef Bley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 2008;58:2574–8.PubMedCrossRef
45.
go back to reference Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging. 2000;11:481–7.PubMedCrossRef Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging. 2000;11:481–7.PubMedCrossRef
46.
go back to reference Kawasaki A, Michel P, Maeder P, Borruat FX. Visualizing the skip lesions of giant cell arteritis with CT arteriography. Eur Neurol. 2009;61:374.PubMedCrossRef Kawasaki A, Michel P, Maeder P, Borruat FX. Visualizing the skip lesions of giant cell arteritis with CT arteriography. Eur Neurol. 2009;61:374.PubMedCrossRef
47.
go back to reference Lefebvre C, Rance A, Paul JF, et al. The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu’s arteritis: a study of 43 patients. Semin Arthritis Rheum. 2000;30:25–32.PubMedCrossRef Lefebvre C, Rance A, Paul JF, et al. The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu’s arteritis: a study of 43 patients. Semin Arthritis Rheum. 2000;30:25–32.PubMedCrossRef
48.
go back to reference Chung JW, Kim HC, Choi YH, et al. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg. 2007;45:906–14.PubMedCrossRef Chung JW, Kim HC, Choi YH, et al. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg. 2007;45:906–14.PubMedCrossRef
49.
go back to reference Brodmann M, Lipp RW, Passath A, et al. The role of 2-18 F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford). 2004;43:241–2.CrossRef Brodmann M, Lipp RW, Passath A, et al. The role of 2-18 F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford). 2004;43:241–2.CrossRef
50.
go back to reference Lehmann P, Buchtala S, Achajew N, et al. 18 F-FDG PET as a diagnostic procedure in large vessel vasculitis-a controlled, blinded re-examination of routine PET scans. Clin Rheumatol. 2011;30:37–42.PubMedCrossRef Lehmann P, Buchtala S, Achajew N, et al. 18 F-FDG PET as a diagnostic procedure in large vessel vasculitis-a controlled, blinded re-examination of routine PET scans. Clin Rheumatol. 2011;30:37–42.PubMedCrossRef
51.
go back to reference •• Besson FL, Parienti JJ, Bienvenu B, et al.: Diagnostic performance of (18)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:1764–72. This is a meta-analysis of six controlled studies evaluating the test characteristics of PET for the diagnosis of GCA. PubMedCrossRef •• Besson FL, Parienti JJ, Bienvenu B, et al.: Diagnostic performance of (18)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:1764–72. This is a meta-analysis of six controlled studies evaluating the test characteristics of PET for the diagnosis of GCA. PubMedCrossRef
Metadata
Title
Recent Advances in Diagnostic Strategies for Giant Cell Arteritis
Authors
Tanaz A. Kermani
Kenneth J. Warrington
Publication date
01-04-2012
Publisher
Current Science Inc.
Published in
Current Neurology and Neuroscience Reports / Issue 2/2012
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-011-0243-6

Other articles of this Issue 2/2012

Current Neurology and Neuroscience Reports 2/2012 Go to the issue

Sleep (M Thorpy and M Billiard, Section Editors)

Effects of Circadian Disruption on Mental and Physical Health

Sleep (M Thorpy and M Billiard, Section Editors)

Sleep-Disordered Breathing in Neurodegenerative Diseases